Lipella Pharmaceuticals Inc. (LIPO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol LIPO
- Company Lipella Pharmaceuticals Inc.
- Price $0.22
- Changes Percentage -23.61
- Change -0.07
- Day Low $0.22
- Day High $0.22
- Year High $7.31
- Year Low $0.17
- Market Cap $1,016,584
- Price Avg 50 EMA (D) $0.25
- Price Avg 200 EMA (D) $0.98
- Exchange NASDAQ
- Volume 371
- Average Volume 10,524
- Open $0.22
- Previous Close $0.29
- EPS -3.81
- PE -0.06
- Earnings Announcement 2025-08-12 04:00:00
- Shares Outstanding $4,620,837
Company brief: LIPELLA PHARMACEUTICALS INC. (LIPO )
- Healthcare
- Biotechnology
- Dr. Jonathan Kaufman M.B.A., Ph.D.
- https://www.lipella.com
- US
- N/A
- 12-19-2022
- US53630L1008
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.